Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OVATION: Iloprost for Vasodilator Assessment in PH
NCT03044314Phase 4Terminated
- Sponsor
- Duke University
- Start
- Jul 2017
- Primary completion
- Jun 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of iloprost in pulmonary hypertension (PH), sponsored by Duke University. Started Jul 2017; status: terminated.
02
Drugs
iloprost
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT03044314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03044314.